BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 18941537)

  • 1. Stat1 phosphorylation determines Ras oncogenicity by regulating p27 kip1.
    Wang S; Raven JF; Durbin JE; Koromilas AE
    PLoS One; 2008; 3(10):e3476. PubMed ID: 18941537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. STAT1 represses Skp2 gene transcription to promote p27Kip1 stabilization in Ras-transformed cells.
    Wang S; Raven JF; Koromilas AE
    Mol Cancer Res; 2010 May; 8(5):798-805. PubMed ID: 20407011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. STAT1 requirement for PKR-induced cell cycle arrest in vascular smooth muscle cells in response to heparin.
    Handy I; Patel RC
    Gene; 2013 Jul; 524(1):15-21. PubMed ID: 23597922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stat1 is an inhibitor of Ras-MAPK signaling and Rho small GTPase expression with implications in the transcriptional signature of Ras transformed cells.
    Wang S; Koromilas AE
    Cell Cycle; 2009 Jul; 8(13):2070-9. PubMed ID: 19502801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of the cell cycle inhibitors p21(Cip1) and p27(Kip1) enhances tumorigenesis in knockout mouse models.
    Jackson RJ; Adnane J; Coppola D; Cantor A; Sebti SM; Pledger WJ
    Oncogene; 2002 Dec; 21(55):8486-97. PubMed ID: 12466968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pim kinases promote cell cycle progression by phosphorylating and down-regulating p27Kip1 at the transcriptional and posttranscriptional levels.
    Morishita D; Katayama R; Sekimizu K; Tsuruo T; Fujita N
    Cancer Res; 2008 Jul; 68(13):5076-85. PubMed ID: 18593906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p27Kip1 repression of ErbB2-induced mammary tumor growth in transgenic mice involves Skp2 and Wnt/beta-catenin signaling.
    Hulit J; Lee RJ; Li Z; Wang C; Katiyar S; Yang J; Quong AA; Wu K; Albanese C; Russell R; Di Vizio D; Koff A; Thummala S; Zhang H; Harrell J; Sun H; Muller WJ; Inghirami G; Lisanti MP; Pestell RG
    Cancer Res; 2006 Sep; 66(17):8529-41. PubMed ID: 16951165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. STAT3-mediated differentiation and survival and of myeloid cells in response to granulocyte colony-stimulating factor: role for the cyclin-dependent kinase inhibitor p27(Kip1).
    de Koning JP; Soede-Bobok AA; Ward AC; Schelen AM; Antonissen C; van Leeuwen D; Löwenberg B; Touw IP
    Oncogene; 2000 Jul; 19(29):3290-8. PubMed ID: 10918585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histone deacetylase inhibitors induce cell death selectively in cells that harbor activated kRasV12: The role of signal transducers and activators of transcription 1 and p21.
    Klampfer L; Huang J; Shirasawa S; Sasazuki T; Augenlicht L
    Cancer Res; 2007 Sep; 67(18):8477-85. PubMed ID: 17875686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stat1 stimulates cap-independent mRNA translation to inhibit cell proliferation and promote survival in response to antitumor drugs.
    Wang S; Patsis C; Koromilas AE
    Proc Natl Acad Sci U S A; 2015 Apr; 112(17):E2149-55. PubMed ID: 25870277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modified p27 Kip1 is efficient in suppressing HER2-mediated tumorigenicity.
    Yang HY; Yang H; Zhao R; Lee MH
    J Cell Biochem; 2006 May; 98(1):128-38. PubMed ID: 16365885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-6 and oncostatin M-induced growth inhibition of human A375 melanoma cells is STAT-dependent and involves upregulation of the cyclin-dependent kinase inhibitor p27/Kip1.
    Kortylewski M; Heinrich PC; Mackiewicz A; Schniertshauer U; Klingmüller U; Nakajima K; Hirano T; Horn F; Behrmann I
    Oncogene; 1999 Jun; 18(25):3742-53. PubMed ID: 10391682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27(Kip1) by PKB/Akt-mediated phosphorylation in breast cancer.
    Viglietto G; Motti ML; Bruni P; Melillo RM; D'Alessio A; Califano D; Vinci F; Chiappetta G; Tsichlis P; Bellacosa A; Fusco A; Santoro M
    Nat Med; 2002 Oct; 8(10):1136-44. PubMed ID: 12244303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A modest reduction in c-myc expression has minimal effects on cell growth and apoptosis but dramatically reduces susceptibility to Ras and Raf transformation.
    Bazarov AV; Adachi S; Li SF; Mateyak MK; Wei S; Sedivy JM
    Cancer Res; 2001 Feb; 61(3):1178-86. PubMed ID: 11221849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytoplasmic p27 is oncogenic and cooperates with Ras both in vivo and in vitro.
    Serres MP; Zlotek-Zlotkiewicz E; Concha C; Gurian-West M; Daburon V; Roberts JM; Besson A
    Oncogene; 2011 Jun; 30(25):2846-58. PubMed ID: 21317921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A small-molecule enhancer of signal transducer and activator of transcription 1 transcriptional activity accentuates the antiproliferative effects of IFN-gamma in human cancer cells.
    Lynch RA; Etchin J; Battle TE; Frank DA
    Cancer Res; 2007 Feb; 67(3):1254-61. PubMed ID: 17283162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorylation of p27(KIP1) in the developing retina and retinoblastoma.
    Kase S; Yoshida K; Nakayama KI; Nakayama K; Ikeda H; Harada T; Harada C; Ohgami K; Shiratori K; Ohno S
    Int J Mol Med; 2005 Aug; 16(2):257-62. PubMed ID: 16012758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclin dependent kinase inhibitor p27(Kip1) is upregulated by hypoxia via an ARNT dependent pathway.
    Wang G; Reisdorph R; Clark RE; Miskimins R; Lindahl R; Miskimins WK
    J Cell Biochem; 2003 Oct; 90(3):548-60. PubMed ID: 14523989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cdk2 is dispensable for cell cycle inhibition and tumor suppression mediated by p27(Kip1) and p21(Cip1).
    Martín A; Odajima J; Hunt SL; Dubus P; Ortega S; Malumbres M; Barbacid M
    Cancer Cell; 2005 Jun; 7(6):591-8. PubMed ID: 15950907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneous p27(Kip1) expression within primary renal cell cancers, their invasive margins and peritumoral renal parenchyma correlation with pathological and prognostic features.
    Merseburger AS; Serth J; von der Heyde E; Kobierski A; Wegener U; Mengel M; Jonas U; Kuczyk M
    Urol Int; 2007; 79(2):164-9. PubMed ID: 17851288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.